A phase 1/2 study of the WEE1 inhibitor Debio 0123 in combination with temozolomide plus radiotherapy in adults with recurrent or newly diagnosed glioblastoma Meeting Abstract
| Authors: | Roth, P.; Papadopoulos, K. P.; Vieito, M.; Yang, J.; Majd, N.; Sepúlveda, J.; Schaff, L.; Moreno, V.; Pérez-Larraya, J. G.; Micallef, S.; Bellon, A.; Omar, M.; Imedio, E. R.; Piggott, L.; Rodriguez-Freixinos, V.; Rodon, J. |
| Abstract Title: | A phase 1/2 study of the WEE1 inhibitor Debio 0123 in combination with temozolomide plus radiotherapy in adults with recurrent or newly diagnosed glioblastoma |
| Meeting Title: | 28th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 25 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2023 Nov 15-19 |
| Meeting Location: | Vancouver, Canada |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-11-01 |
| Start Page: | v258 |
| End Page: | v259 |
| Language: | English |
| ACCESSION: | WOS:001115245401205 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/noad179.0994 |
| Notes: | Meeting Abstract: RTID-03 -- Source: Wos |
